A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1565-1569

  Gundersen, S ^a   Lote, K ^a   Watne, K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemotherapy; Grade 3 and 4 gliomas; Intra arterial carmustine

Indexed keywords

CARMUSTINE; PROCARBAZINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFECT; FEMALE; GLIOMA; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADULT; AGE DISTRIBUTION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CHEMOTHERAPY, ADJUVANT; GLIOBLASTOMA; HUMANS; INFUSIONS, INTRA-ARTERIAL; LOMUSTINE; MIDDLE AGED; PROCARBAZINE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0032168947     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00146-4     Document Type: Article

References (22)

1. 1. Anderson AP. Post-operative irradiation of glioblastomas. Results in a randomised series. Acta Radiol 1978, 17, 475-484.
2. 2. Loeffler JS. Radiotherapy in managing malignant gliomas: current role and future directions. Adv Oncol 1992, 8, 14-20.
3. 3. Brisman R, Housepian EM, Chang C, et al. Adjuvant nitrosurea therapy for glioblastoma. Arch Neurol 1976, 33, 745-750.
4. 4. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978, 49, 333-343.
5. 5. Kristiansen K, Hagen S, Kollevold T, Torvik A, et al. Combined modality therapy of operated astrocytomas grades III and IV. Confirmation of the value of post-operative irradiation and lack of potentiation of bleomycin on survival time. Cancer 1981, 4, 649-652.
6. 6. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978, 49, 333-343.
7. 7. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 1980, 303, 1323-1329.
8. 8. Green SB, Byar DP, Walker MD, et al. Comparison of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983, 67, 121-132.
9. 9. Chang CH, Horton J, Schoenfeld D, et al. Comparison of post-operative radiotherapy and combined post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983, 52, 997-1007.
10. 10. Eyre HJ, Quagliana JM, Eltringham JR, et al. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neuro-Oncol 1983, 1, 171-177.
11. 11. Nelson DF, Diener-West M, Horton J, et al. Combined modality approach to treatment of malignant gliomas-reevaluation of RTOG 7401/ECOG 1374 with long-term follow up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monographs 1988, 6, 279-284.
12. 12. Deutsch M, Green SB, Strike AS, et al. Results of a randomized trial comparing BCNU plus radiotherapy, Streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following Misonidazole plus radiotherapy in the post-operative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989, 16, 1389-1396.
13. 13. Fine HA, Dear KGB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without chemotherapy in malignant glio-mas in adults. Cancer 1993, 71, 2585-2597.
14. 14. Lote K, Gundersen S, Hannisdal E, et al. Prognosen ved primare svulster i sentralnervesystemet. Det Norske Radiumhospitals pasientmateriale 1980-1994. Tidsskr Nor Legeforen 1996, 11, 1320-1324.
15. 15. Black PM. Brain tumors. Part 1. N Engl J Med 1991, 324, 1471-1476.
16. 16. Black PM. Brain tumors. Part 2. N Engl J Med 1991, 324, 1555-1564.
17. 17. Gundersen S, Lote K, Hannisdal E. Prognostic factors for glioblastoma multiforme - Development of prognostic index. Acta Oncol Suppl 1996, 8, 123-127.
18. 18. Watne K, Nome O, Hager B, et al. Combined intra-arterial chemotherapy and irradiation of malignant gliomas. Acta Oncol 1991, 7, 835-841.
19. 19. International Histologic Classification of Tumours No. 21. Histologic typing of tumours of the central nervous system. Geneva, WHO, 1979.
20. 20. Peto R, Pike MC Armitage P, et al. Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 1977, 35, 1-39.
21. 21. Shapiro WR, Sylvan SB, Burger PC, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992, 76, 772-781.
22. 22. A report of the Medical Research Council Brain Tumour Working Party. Prognostic factors for high-grade malignant glioma; development of a prognostic index. J Neuro-Oncol 1990, 9, 47-55.